济川药业(600566.SH)拟认购博远境诚三期股权投资合伙企业份额

智通财经08-16

智通财经APP讯，济川药业(600566.SH)发布公告，公司全资子公司济川有限于近日签订了《杭州博远境诚三期股权投资合伙企业(有限合伙)之有限合伙协议》，作为有限合伙人以自有资金参与认购博远境诚三期的出资份额人民币5000万元。据悉，博远境诚三期主要通过对在中国区域内设立的或主要运营在中国境内的医药、生物科技、医疗服务、医疗器械、设备、诊断、医疗IT、医疗健康、动物保健及其上下游潜在应用等相关...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2459996562?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-16 18:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2459996562","market":"hk","top_or_hot":-1,"title":"济川药业(600566.SH)拟认购博远境诚三期股权投资合伙企业份额","media":"智通财经","content":"<div>\n<p>智通财经APP讯，济川药业(600566.SH)发布公告，公司全资子公司济川有限于近日签订了《杭州博远境诚三期股权投资合伙企业(有限合伙)之有限合伙协议》，作为有限合伙人以自有资金参与认购博远境诚三期的出资份额人民币5000万元。据悉，博远境诚三期主要通过对在中国区域内设立的或主要运营在中国境内的医药、生物科技、医疗服务、医疗器械、设备、诊断、医疗IT、医疗健康、动物保健及其上下游潜在应用等相关...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1165499.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>济川药业(600566.SH)拟认购博远境诚三期股权投资合伙企业份额</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n济川药业(600566.SH)拟认购博远境诚三期股权投资合伙企业份额\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-16 18:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1165499.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，济川药业(600566.SH)发布公告，公司全资子公司济川有限于近日签订了《杭州博远境诚三期股权投资合伙企业(有限合伙)之有限合伙协议》，作为有限合伙人以自有资金参与认购博远境诚三期的出资份额人民币5000万元。据悉，博远境诚三期主要通过对在中国区域内设立的或主要运营在中国境内的医药、生物科技、医疗服务、医疗器械、设备、诊断、医疗IT、医疗健康、动物保健及其上下游潜在应用等相关...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1165499.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1165499.html","article_id":"2459996562","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2459996562","pubTimestamp":1723802721,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，济川药业(600566.SH)发布公告，公司全资子公司济川有限于近日签订了《杭州博远境诚三期股权投资合伙企业(有限合伙)之有限合伙协议》，作为有限合伙人以自有资金参与认购博远境诚三期的出资份额人民币5000万元。据悉，博远境诚三期主要通过对在中国区域内设立的或主要运营在中国境内的医药、生物科技、医疗服务、医疗器械、设备、诊断、医疗IT、医疗健康、动物保健及其上下游潜在应用等相关领域(“医疗领域”)及其他领域的企业进行股权投资或以股权投资为目的的可转债投资。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600566":"济川药业","BK0188":"融资融券","BK0028":"国家队","BK0187":"一线龙头","BK0201":"可转债","BK0012":"证金概念","BK0077":"质押式回购","BK0239":"医药制造"},"translate_title":"Jichuan Pharmaceutical (600566. SH) plans to subscribe for the share of Boyuan Jingcheng Phase III Equity Investment Partnership","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600566":1},"content_text":"智通财经APP讯，济川药业(600566.SH)发布公告，公司全资子公司济川有限于近日签订了《杭州博远境诚三期股权投资合伙企业(有限合伙)之有限合伙协议》，作为有限合伙人以自有资金参与认购博远境诚三期的出资份额人民币5000万元。据悉，博远境诚三期主要通过对在中国区域内设立的或主要运营在中国境内的医药、生物科技、医疗服务、医疗器械、设备、诊断、医疗IT、医疗健康、动物保健及其上下游潜在应用等相关领域(“医疗领域”)及其他领域的企业进行股权投资或以股权投资为目的的可转债投资。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2459996562"}